Clofarabine, idarubicin, and cytarabine (CIA) as frontline therapy for patients ≤60 years with newly diagnosed acute myeloid leukemia.
about
Progress in acute myeloid leukemia'Acute myeloid leukemia: a comprehensive review and 2016 update'SLC29A1 single nucleotide polymorphisms as independent prognostic predictors for survival of patients with acute myeloid leukemia: an in vitro studyThe role of the gastrointestinal microbiome in infectious complications during induction chemotherapy for acute myeloid leukemia.G-CSF priming, clofarabine, and high dose cytarabine (GCLAC) for upfront treatment of acute myeloid leukemia, advanced myelodysplastic syndrome or advanced myeloproliferative neoplasm.Treatment with Hypomethylating Agents before Allogeneic Stem Cell Transplant Improves Progression-Free Survival for Patients with Chronic Myelomonocytic Leukemia.Characterization of oral and gut microbiome temporal variability in hospitalized cancer patients.Inching toward cure of acute myeloid leukemia: a summary of the progress made in the last 50 years.Acute myeloid leukemia--major progress over four decades and glimpses into the future.SLC29A1 (ENT1) polymorphisms and outcome of complete remission in acute myeloid leukemia.Frontline treatment of acute myeloid leukemia in adults.Emerging strategies for the treatment of older patients with acute myeloid leukemia.Addition of cladribine to the standard induction treatment improves outcomes in a subset of elderly acute myeloid leukemia patients. Results of a randomized Polish Adult Leukemia Group (PALG) phase II trial.Low-dose clofarabine in combination with a standard remission induction in patients aged 18-60 years with previously untreated intermediate and bad-risk acute myeloid leukemia or high-risk myelodysplastic syndrome: combined phase I/II results of thePeripheral blood blast clearance is an independent prognostic factor for survival and response to acute myeloid leukemia induction chemotherapyA phase I/II randomized trial of clofarabine or fludarabine added to idarubicin and cytarabine for adults with relapsed or refractory acute myeloid leukemia.Chemomodulation of sequential high-dose cytarabine by fludarabine in relapsed or refractory acute myeloid leukemia: a randomized trial of the AMLCG.A randomized phase 2 study of idarubicin and cytarabine with clofarabine or fludarabine in patients with newly diagnosed acute myeloid leukemia.ABCG2 overexpression and deoxyadenosine analogue activity in acute myeloid leukemia.Combination of clofarabine, cyclophosphamide, and etoposide for relapsed or refractory childhood and adolescent acute myeloid leukemia.Persistence of minimal residual disease assessed by multiparameter flow cytometry is highly prognostic in younger patients with acute myeloid leukemia.
P2860
Q27024006-EDD89F9D-67DC-40DA-9F1B-9800828B98FFQ28072539-855BBACC-17E9-48AD-9C85-9D378261A6D1Q34528361-FE7D76A2-309F-42DA-9389-2F87B7A0CC83Q36007787-B19B2133-465A-47D3-91D2-FB2FB2F11E9AQ36478979-D6541E6F-BBC8-487A-A2B8-0376C901903EQ36967029-4C0B709E-0203-48D5-98D6-4228F1A1DAB0Q37673349-3BEC6804-6F99-4542-A20A-483A744C2514Q38232465-81212984-B0E9-4350-AA58-CDF2520A1484Q38644941-49A62F2E-CDF9-43F0-99BF-511B420495BFQ38757910-38A4C82B-7CA3-4AA9-89A8-523337F76C17Q38767583-08633217-5E6C-42C0-B50B-3BE109BCFEF2Q38818726-2E597F56-1F3B-4177-B674-3BB4A0A729A2Q40373192-17DD3C71-6B03-4494-B823-9C55D605D5B7Q42325009-884B7FB2-6CC7-42CF-9F76-45DE12BAE39AQ42365051-598E07C8-9782-4507-A91B-8F92AB4B745CQ44041367-F7D6606F-A8A0-4793-87D8-CA6FDDFF5716Q45250906-99CF04EF-3DA7-478B-A10B-2F37A6870002Q46744333-A58DD9A2-D968-404F-9525-1F7CA9636565Q48155231-167C5B92-135D-4914-87A4-F276B2A06BF7Q48175362-FE1DD210-1AEB-4A3C-884C-1C035C937E14Q50355902-8FF7125E-7474-44D2-8B44-FB14D6A7654A
P2860
Clofarabine, idarubicin, and cytarabine (CIA) as frontline therapy for patients ≤60 years with newly diagnosed acute myeloid leukemia.
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Clofarabine, idarubicin, and c ...... gnosed acute myeloid leukemia.
@ast
Clofarabine, idarubicin, and c ...... gnosed acute myeloid leukemia.
@en
type
label
Clofarabine, idarubicin, and c ...... gnosed acute myeloid leukemia.
@ast
Clofarabine, idarubicin, and c ...... gnosed acute myeloid leukemia.
@en
prefLabel
Clofarabine, idarubicin, and c ...... gnosed acute myeloid leukemia.
@ast
Clofarabine, idarubicin, and c ...... gnosed acute myeloid leukemia.
@en
P2093
P2860
P50
P356
P1476
Clofarabine, idarubicin, and c ...... gnosed acute myeloid leukemia.
@en
P2093
Aziz Nazha
Mark Brandt
Naval Daver
Naveen Pemmaraju
Sangbum Choi
Steve Kornblau
Xuelin Huang
P2860
P304
P356
10.1002/AJH.23544
P50
P577
2013-09-09T00:00:00Z